Clinical Trial Update: A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)

View source ↗

Summary

A long-term follow-up study is being conducted for subjects enrolled in trials of Cadonilimab (AK104) for gastric cancer, with the study currently in recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Cadonilimab (AK104) (Cadonilimab)

Snippet

Sponsor: Akeso | Conditions: Locally Advanced Unresectable or Metastatic Gastric Cancer | Status: RECRUITING